Stock listing

TLX Stock Price, News, Filings & Events — Telix Pharmaceuticals Limited

Selected listing: TLX · NASDAQ · USD · US

The TLX:NASDAQ listing represents Telix Pharmaceuticals Limited, a biopharmaceutical company focused on the development of innovative cancer treatments. The company specializes in targeted therapies that utilize its proprietary radiopharmaceuticals to improve patient outcomes. Recent news highlights Telix's ongoing clinical trials and regulatory filings aimed at advancing its product pipeline. Investors can stay informed about upcoming events and market developments that may impact the company's performance.

TLX:NASDAQUSDUSUpdated July 21, 2026
Telix Pharmaceuticals Limited logo
Ticker
TLX:NASDAQ
Asset type
Stock
Market cap
$3.71B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Telix Pharmaceuticals Limited TLX:NASDAQ stock context

The TLX:NASDAQ listing represents Telix Pharmaceuticals Limited, a biopharmaceutical company focused on the development of innovative cancer treatments. The company specializes in targeted therapies that utilize its proprietary radiopharmaceuticals to improve patient outcomes. Recent news highlights Telix's ongoing clinical trials and regulatory filings aimed at advancing its product pipeline. Investors can stay informed about upcoming events and market developments that may impact the company's performance.

Research Telix Pharmaceuticals Limited

Alternate listings